Success Stories: A Senior Research Data Analyst from India in the field of Data Science achieves EB1A Case Approval in Just 24 days with the Help of Our Assistance and Premium Processing!
Client’s Testimonial:
“Thank you very much. This is great news for us.”
On January 13th, 2025, we received another EB-1A (Alien of Extraordinary Ability) approval for a Senior Research Data Analyst in the field of Data Science (Approval Notice).
General Field: Data Science
Position at the Time of Case Filing: Senior Research Data Analyst
Country of Origin: India
State of Residence at the Time of Filing: Maryland
Approval Notice Date: January 13th, 2025
Processing Time: 24 days (Premium Processing Requested)
Case Summary:
A senior research data analyst contacted our law firm to help him establish his significant contributions to the U.S. by filing for an EB-1A (Alien of Extraordinary Ability) petition. We presented his exceptional professional background and unparalleled experience important to his current and future work at the USCIS.
Upon reviewing his credentials, we found that our client has an M.S. in electrical engineering and an M.S. in Business analytics and has accomplished a great publication record in his field. His research resulted in:
- 22 peer-reviewed journal articles (1 first-authored), 15 conference articles (2 first-authored), 14 abstracts (1 first-authored), and 3 book chapters, and these papers have been published in some of the most discerning, high-impact journals in his field of expertise.
- He has conducted at least 80 reviews for journals to date and his work has been cited by other scholars in numerous published articles as well.
- According to Google Scholar, his work has been cited 604 times in at least 43 countries.
- His study has received funding from such prestigious organizations as the Department of Defense, the Radiological Society of North America, the National Cancer Institute, the Sonya A. Sinicki Foundation for Cancer Research, the National Institute of Arthritis and Musculoskeletal and Skin Diseases, the National Institute of Biomedical Imaging and Bioengineering, the National Heart, Lung, and Blood Institute, and the Eunice Kennedy Shriver National Institute of Child Health and Human Development.
His case was further supported by including four recommendation letters that he obtained from his fellow experts in the field. One of the recommenders stated:
“The current American healthcare system is hindered by inefficiencies due to the continued prescription of generalized treatment…As such, [Client’s] research has widespread implications in this regard, as his work on integrating predictive modeling with personalized treatment ensures that all patients receive the care they need according to their symptoms. In this way, he pioneers innovation in the healthcare system, ensuring that medical resources are utilized as efficiently as possible and given to patients who require them most. In totality, [client’s] work not only advances the efficiency of medical treatment but also allows the United States to maintain a sustainable and evolving healthcare system, thereby solidifying its global standing as a leader in medical innovation.”
Our team’s efforts successfully paid off in conveying to the USCIS that our client is an extraordinary researcher who seeks to enter the United States to continue working in his field of expertise. His extraordinary ability has been demonstrated by sustained international acclaim, and his achievements have been recognized in the field through implementation by others and extensive citation of his work.We would like to congratulate him on securing EB1A approval and thanks to the Premium Processing service, he received his approval in only 24 days. We wish him to receive his green card as soon as possible.